Status:
COMPLETED
Early Detection of Five Common Cancers Using the ctDNA Analysing Test
Lead Sponsor:
Gene Solutions
Collaborating Sponsors:
Medical University of Ho Chi Minh City
Hanoi Medical University
Conditions:
Cancer, Lung
Cancer, Breast
Eligibility:
All Genders
40+ years
Brief Summary
This is a multi-centre, prospective cohort study, aiming to evaluate a blood test in early detection of the four common cancers, based on the investigation of the circulating tumour DNA (ctDNA). Prim...
Detailed Description
This is a multi-centre, prospective cohort study recruiting participants aged 40 or above, who present at the Outpatient Clinic of the study hospitals either for periodically follow-up visits for thei...
Eligibility Criteria
Inclusion
- Aged 40 or above at enrolment
- Neither clinical suspicion of cancer nor history of confirmed cancer has been reported
- Agree to be contacted at 6 months and 12 months following enrolment to collect information about general health status and progress of cancer (if possible)
- Provide written informed consent
Exclusion
- If a potential participant has any one of the following criteria, he/she will not be able to be enrolled in the study:
- History of cancer (cancer has either been confirmed or been treated within the past 3 years)
- History of blood transfusion or bone marrow transplantation within the past 3 years
- Does not agree to participate in study
- The subject has clinical manifestations of pregnant.
Key Trial Info
Start Date :
April 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2024
Estimated Enrollment :
9057 Patients enrolled
Trial Details
Trial ID
NCT05227261
Start Date
April 10 2022
End Date
April 10 2024
Last Update
February 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanoi medical university
Hanoi, Vietnam